Related Experiment Videos
Systemic lupus erythematosus with myocardial dysfunction due to microvasculopathy
Y Nanke1, S Kotake, K Shimamoto
1The Institute of Rheumatology, Tokyo Women's Medical University, Japan. ynn@murayama.hosp.go.jp
Lupus
|September 12, 2000
Summary
Systemic lupus erythematosus (SLE) can cause myocardial dysfunction due to microvasculopathy, not thrombi. Corticosteroid therapy proved effective in this unique case of cardiac involvement in SLE.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with potential multi-organ involvement.
- Cardiac manifestations in SLE, though known, often present with diverse pathologies.
- Myocardial dysfunction in SLE patients requires precise etiological diagnosis for effective management.
Observation:
- A 25-year-old Japanese woman with SLE presented with significant myocardial dysfunction.
- Diagnostic workup including heart catheterization and left ventricular cineangiography revealed normal coronary arteries but regional hypokinesis.
- Myocardial scintigraphy showed patchy defects unrelated to coronary artery disease.
Findings:
- The observed myocardial dysfunction was attributed to microvasculopathy, a condition affecting small blood vessels.
- Evidence suggested vasculitis, rather than thrombotic events, as the cause of microvasculopathy, supported by the absence of antiphospholipid syndrome.
- The patient's positive response to corticosteroid therapy further supported the vasculitic etiology.
Implications:
- This case highlights the potential for SLE-induced microvasculopathy to cause myocardial dysfunction.
- It underscores the importance of considering non-atherosclerotic causes of cardiac dysfunction in SLE patients.
- The findings suggest that targeted immunosuppressive therapy, like corticosteroids, can be effective in managing SLE-related cardiac microvasculopathy.